Article Sidebar

Download
PDF

Main Article Content

Abstract

RÉSUMÉ
Introduction. La riposte contre la pandémie  à  COVID-19  a entrainé le report des consultations non urgentes pouvant impacter sur l’évolution du glaucome. Le but de ce travail était d’évaluer les effets des mesures barrières  sur le suivi du glaucome. Matériels et méthodes. Nous avons réalisé un sondage sur l’impact  de la Covid 19 sur le suivi des  patients glaucomateux en  mai 2020.  Le questionnaire comportait 12 items portant sur les caractéristiques sociodémographiques, l’impact de la COVID 19 sur le suivi du glaucome  et  la  connaissance de l’infection au SARS cov-2.  Résultats. 24 personnes ont  participé au sondage  soit 14 femmes  et 10 hommes, pour  un sex  ratio de 0,71. Leur moyenne d’âge était de 57 ans ±13.77. Les mesures prises par l’hôpital ont été accepté à l’exception du report des consultations (16,67%) et le port obligatoire du masque (12,50%). 21 patients (87.50%) n’ont éprouvé aucune difficulté à rencontrer leur médecin. Sur 14 personnes, 11 patients estiment que le forum « Clinique du glaucome » leur donne la possibilité d’avoir des réponses à leurs préoccupations. Un total cumulé de 10 rendez-vous ont  été annulé. 22 patients sur 24 ont continué  leur traitement. Les 2 patients qui l’ont arrêté  ont évoqué des raisons financières. 17 patients (70.83 %)  estiment être informés sur la pandémie. 62 % des patients estiment qu’un renforcement de la sensibilisation  améliorerait leur suivi.  Conclusion. le forum «Clinique du glaucome » a permis de mitiger les effets des mesures barrières.

ABSTRACT
Introduction. The response to the pandemic to COVID-19 led to the postponement of non-urgent consultations which could have an impact on the course of glaucoma. The aim of this work was to evaluate the effects of barrier measures on the monitoring of glaucoma. Materials and methods. We conducted a survey on the impact of Covid 19 on the follow-up of glaucoma patients in May 2020. The questionnaire included 12 items dealing with socio-demographic characteristics, the impact of COVID 19 on the follow-up of glaucoma and knowledge of infection with SARS cov-2. Results. 24 people took part in the survey, i.e. 14 women and 10 men, for a sex ratio of 0.71. Their average age was 57 ±13.77.The measures taken by the hospital were accepted except for the postponement of consultations (16.67%) and the compulsory wearing of a mask (12.50%). 21 patients (87.50%) had no difficulty seeing their doctor. Out of 14 people, 11 patients believe that the “Glaucoma Clinic” forum gives them the opportunity to have their concerns answered. A cumulative total of 10 appointments have been canceled. 22 out of 24 patients continued their treatment. The 2 patients who stopped their treatment mentioned financial reasons. 17 patients (70.83%) believe they are well informed about the pandemic. 62% of patients believe that increased awareness would improve their follow-up. Conclusion. The "Glaucoma Clinic" forum helped mitigate the effects of barrier measures.

Keywords

COVID-19 glaucome

Article Details

How to Cite
Nanfack Ngoune, C., Nomo, A. F., Mvilongo Tsimi, C., Akono Zoua, M. E., Epee, E., & Bella, A. L. (2020). Influence de la Pandémie à COVID-19 sur le Suivi des Patients Glaucomateux à l’Hôpital Gynéco-Obstétrique et Pédiatrique de Yaounde. HEALTH SCIENCES AND DISEASE, 21(11). https://doi.org/10.5281/hsd.v21i11.2380
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Pneumonia of unknown cause—China: disease outbreak news. World Health Organization, Geneva. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. Accessed 14 Apr 2020
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 DOI: 10.1016/S0140-6736(20)30183-5.
  3. Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. Novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis. J Med Virol. 2019 doi: 10.1002/jmv.25757.
  4. CDC How coronavirus spreads. Available: https://www.cdc.gov/coronavirus/2019-ncov/prepare/transmission.html [Accessed 27 Mar 2020].
  5. Tahiri R, Hassani J, Sandali O. Le nouveau Coronavirus Covid-19 : quels risques ophtalmiques ? J Fr Ophtalmol. 2020 Apr; 43(4): 291–293.
  6. Fong MW, Gao H, Wong JY, et al. Non pharmaceutical measures for pandemic influenza in non-healthcare settings-social distancing measures. Emerg Infect Dis. 2020; 26:976–984. doi: 10.3201/eid2605.190995.
  7. Liebmann JM. Ophthalmology and glaucoma practice in the COVID-19 Era. J Glaucoma. 2020. DOI: [Epub ahead of print] [PMC free article] [PubMed]
  8. American Academy of Ophthalmology Alert: important coronavirus updates for ophthalmologists. Available: https://www.aao.org/headline/alert-important-coronavirus-context [Accessed 27 Mar 2020].
  9. wei LC, fen LX, fang JZ. 2019-nCoV transmission through the ocular surface must not be ignored. The Lancet 2020; 395:e39.
  10. Li HK. Telemedicine and ophthalmology. Surv Ophthalmol, 1999; 44:61–72.
  11. Field MJ. Telemedicine: a guide to assessing telecommunications in healthcare. J Digit Imaging. 1997;10(3 Suppl 1):28. doi:10.1007/BF03168648
  12. .Ramesh Sathyamangalam , Pradeep G Paul, Ronnie George, Mani Baskaran, Arvind Hemamalini, Raj V Madan, J Augustian, Raju Prema, Vijaya Lingam. Determinants of glaucoma awareness and knowledge in urban Chennai. Indian J Ophthalmol. 2009 Sep-Oct; 57(5): 355–360.
  13. Achigbu EO, Chuka-Okosa CM, Achigbu KI. The knowledge, perception, and attitude of patients living with glaucoma and attending the eye clinic of a secondary health care facility in south-east, Nigeria. Niger J Ophthalmol. 2015; 23:1–6.
  14. Adegbehingbe BO1, Bisiriyu LA .Impact of Education on Knowledge Attitude and Practice (KAP) of Glaucoma Patients towards their Disease Management- a Study. Journal of Pharmaceutical Research & Clinical Practice, Jan-Mar 2013; 3(1):8-12
  15. Palmer K, Monaco A, Kivipelto M, Onder G, Maggi S. The potential long‑term impact of the COVID‑19 outbreak on patients with non‑communicable diseases in Europe: consequences for healthy ageing. Aging Clinical and Experimental Research (2020) 32:1189–1194
  16. Syndicat national des ophtalmologistes de France. Ophtalmologie – Étude Snof Covid-19 : les ophtalmologistes s’organisent. Communiqué de presse –3 avril 2020.
  17. Monaco A, Palmer K, Margengoni A, et al. Integrated care for the management of ageing-related non-communicable diseases: current gaps and future directions. Aging Clin Exp Res. 2020 doi: 10.1007/s40520-020-01533-z.
  18. Monaco A, Maggi S, De Cola P, Hassan T A, Palmer K, Donde S. Information and communication technology for increasing healthy ageing in people with non-communicable diseases: identifying challenges and further areas for development. Aging Clin Exp Res. 2019; 31:1689–1693.

Most read articles by the same author(s)

1 2 3 > >>